Dapivirine Completed Phase 1 Trials for Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT03393468Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults
NCT03239483Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults
NCT01548560Assessing the Safety of Dapivirine Gel and Film Formulations
NCT00700284Feasibility Study of a Vaginal Ring for Delivery of TMC120 (Dapivirine)
NCT00469768A Pharmacokinetic Study of Dapivirine Vaginal Rings in Belgium
NCT00332995Safety and Feasibility Study of Dapivirine (TMC120) Vaginal Ring in Belgium
NCT00613249A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels
NCT00304642A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel